Mechanism of action of dietary chemoprotective agents in rat liver: Induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism

Carcinogenesis

Volumn 18, Issue 9, 1997, Pages 1729-1738

  Manson, Margaret M ^a   Ball, Helen W L ^a   Barrett, Mandy C ^a   Clark, Helen L ^a   Judah, David J ^a   Williamson, Gary ^b   Neal, Gordon E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; AFLATOXIN B1; ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; BUTYLCRESOL; CAFFEIC ACID; CATECHOL DERIVATIVE; CYTOCHROME P450 ISOENZYME; DRUG METABOLIZING ENZYME; ETHOXYQUIN; GALLIC ACID PROPYL ESTER; GAMMA GLUTAMYLTRANSFERASE; GARLIC OIL; GLUTATHIONE TRANSFERASE; LIVER PROTECTIVE AGENT; OLTIPRAZ; PHENETHYL ISOTHIOCYANATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SINIGRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONJUGATION; CONTROLLED STUDY; DIET; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; ENZYME INDUCTION; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL; LIVER METABOLISM; LIVER MICROSOME METABOLISM; LIVER PROTECTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; WINE;

AFLATOXIN B1; ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; CYTOCHROME P-450 ENZYME SYSTEM; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; MALE; MICROSOMES, LIVER; ORGAN SIZE; PROTECTIVE AGENTS; RATS; RATS, INBRED F344;

EID: 0031428462     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.9.1729     Document Type: Article

References (76)

1. Block, G., Patterson, B. and Subar, A. (1992) Fruit, vegetables and cancer prevention. A review of the epidemiological evidence. Nutr. Cancer, 18, 1-29.
2. Negri, E., La Vecchia, C., Franceschi, S., D'Avanzo, B. and Parazzini, F. (1991) Vegetable and fruit consumption and cancer risk. Int. J. Cancer, 48, 350-354.
3. 1-induced rat plasma α-foetoprotein elevation, hepatic tumorigenesis, and mutagenicity of urine. Food Chem. Toxicol., 20, 47-52.
4. Xu, Y., Ho, C.-T., Amin, S.G., Han, C. and Chung, F.-L. (1992) Inhibition of tobacco specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res., 52, 3875-3879.
5. Ho, C.-T., Ferraro, T., Chen, Q., Rosen, R.T. and Huang, M-T. (1994) Phytochemicals in teas and rosemary and their cancer-preventive properties. In Ho, C.-T., Toshihiko, O., Huang, M.-T. and Rosen, R.T. (eds) Food Phytochemicals for Cancer Prevention. 11 ACS Symposium series 547, ACS, Washington, DC, pp. 2-19.
6. Teel, R.W. (1991) Effect of capsaicin on rat liver S9-mediated metabolism and DNA binding of aflatoxin. Nutr. Cancer, 15, 27-32.
7. Huang, M.-T. and Ferraro, T. (1992) Phenolic compounds in food and cancer prevention. In Huang, M.-T., Ho, C. and Lee, C.Y. (eds) Phenolic Compounds in Food and their Effects on Health. 11 ACS Symposium series 507, New York, pp. 8-34.
8. Fleuri, Y, Welti, D.H., Philippossian, G. and Magnolato, D. (1992) Soybean (malonyl) isoflavones, characterisation and antioxidant properties in food and their effect on health. In Huang, M.-T., Ho, C. and Lee, C.Y. (eds) Phenolic Compounds in Food and their Effect on Health. 11 ACS Symposium Series 507, New York, pp. 98-113.
9. 1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis, 7, 1043-1050.
10. 1 hepatocarcinogenesis in the rat. Cancer Res., 47, 5218-5223.
11. 1 by several forms of purified cytochrome P450. Mutat. Res., 174, 85-88.
12. 1. Pharmacol. Ther., 50, 443-472.
13. 1, is expressed in rat liver during carcinogenesis and following the administration of an antioxidant. Biochem. J., 292, 13-18.
14. 1 conjugates. Carcinogenesis, 5, 869-874.
15. Prochaska, H.J., Santamaria, A.B. and Talalay, P. (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl Acad. Sci. USA, 89, 2394-2398.
16. Tawfiq, N., Heaney, R.K., Plumb, J.A., Fenwick, G.R., Musk, S.R.R. and Williamson, G. (1995) Dietary glucosinolates as blocking agents against carcinogenesis: glucosinolate breakdown products assessed by induction of quinone reductase activity in murine Hepa 1c1c 7 cells. Carcinogenesis, 16, 1191-1194.
17. Heaney, R.K. and Fenwick, G.R. (1985) Brassica vegetables, a major source of glucosinolates in the human diet. In Sorensen, H. (Ed.) Advances in the Production and Utilisation of Cruciferous Crops. Martinus Nijhoff, Dordrecht, pp. 40-49.
18. Stoner, G.D., Morrissey, D.T., Heur, Y.H., Daniel, E.M., Galati, A.J. and Wagner, S.A. (1991) Inhibitory effects of phenethylisothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat oesophagus. Cancer Res., 51, 2063-2068.
19. Loft, L., Otte, J., Poulsen, H.E. and Sorensen, H. (1992) Influence of intact and myrosinase treated indolyl glucosinolates on the metabolism in vivo of metronidazole and antipyrine in the rat. Food Chem. Toxicol., 30, 927-935.
20. Verma, A.K., Johnson, J.A., Gould, M.N. and Tanner, M.A. (1988) Inhibition of 7,12-diethylbenz[a]anthracene and N-nitrosomethyl urea-induced rat mammary cancer by the dietary flavonol quercitin. Cancer Res., 48, 5754-5758.
21. Wattenberg, L.W., Coccia, J.B. and Lam, L.K.T. (1980) Inhibitory effects of phenolic compounds on benzo[a]pyrene induced neoplasia. Cancer Res., 40, 2820-2823.
22. Dausch, J.G. and Nixon, D.W. (1990) Garlic: a review of its relationship to malignant disease. Prevent. Med., 19, 346-361.
23. Ernst, E., Weihmayr, T.H. and Matrai, A. (1985) Garlic and blood lipids. Br. Med. J., 291, 139.
24. 1. Nutr. Cancer, 15, 87-95.
25. Wargovich, M.J., Woods, C., Eng, V.W.S., Stephens, C. and Gray, K. (1988) Chemoprevention of N-nitrosomethylbenzylamine-induced oesophageal cancer in rats by the naturally occurring thioether, diallyl sulphide. Cancer Res., 48, 4872-4875.
26. Kanner, J., Frankel, E., Granit, R., German, B. and Kinsella, J.E. (1994) Natural antioxidants in grapes and wine. J. Agric. Food Chem., 42, 64-69.
27. PaceAsciaka, C.R., Hahn, S., Diamandis, E.P., Soleas, G. and Goldberg, D.M. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 235, 207-219.
28. De Long, M.J., Prochaska, H.J. and Talalay, P. (1985) Tissue specific induction patterns of cancer-protective enzymes in mice by tery-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res., 45, 546-551.
29. Kensler, T.W. and Helzlsouer, K.J. (1995) Oltipraz: Clinical opportunities for cancer chemoprevention. J. Cell Biochem., Suppl. 22, 101-107.
30. Rushmore, T.A., Nguyen, T. and Pickett, C.B. (1993) ARE and XRE-mediated induction of glutathione transferase Ya subunit gene. Induction by planar aromatic compounds and phenolic antioxidants. In Tew, K.D., Pickett, C.B., Mantle, T.J., Mannervick, B. and Hayes, J.D. (eds) Structure and Function of Glutathione-S-Transferases. CRC Reviews, pp. 119-128.
31. 1 in rats. Cancer Lett., 19, 125-132.
32. Kensler, T.W., Egner, P.A., Davidson, N.E., Roebuck, B.D., Pikul, A. and Groopman, J.D. (1986) Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer Res., 46, 3924-3931.
33. 1 in rats. Carcinogenesis, 12, 459-462.
34. Kensler, T.W., Egner, P.A., Dolan, P.M., Groopman, J.D. and Roebuck, B.D. (1987) Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res., 47, 4271-4277.
35. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz), predictive role for short-term molecular dosimetry. Cancer Res., 51, 5501-5506.
36. Cha, Y-M. and Heine, H.S. (1982) Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res., 42, 2609-2615.
37. Brouard, C., Siess, M.H., Vernevaut, M.F. and Suschetet, M. (1988) Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat. Food. Chem. Toxicol., 26, 99-103.
38. Wortelboer, H.M., Van der Linden, E.C.M., Kruif, C.A., Noordhoek, J., Blaaboer, B.J., Van Bladeren, P.J. and Falke, H.E. (1992) Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures. Food Chem. Toxicol., 30, 589-599.
39. Nijhoff, W.A., Groen, G.M. and Peters, W.H.M. (1993) Induction of rat hepatic and intestinal glutathione S-transferases and glutathione by naturally occurring anticarcinogens. Int. J. Oncol., 3, 1131-1139.
40. Egner, P.A., Kensler, T.W., Prestera, T., Talalay, P., Libby, A.H., Joyner, H.H. and Curphey, T.J. (1994) Regulation of phase 2 enzyme induction by oltipraz and other dithiolthiones. Carcinogenesis, 15, 177-181.
41. Stresser, D.M., Williams, D.E., McLellan, L.I., Harris, T.M. and Bailey, G.S. (1994) Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin AFB, exo-epoxide - association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. Drug Metab. Disp., 22, 392-399.
42. 1 in the rat. Drug Metab. Disp., 22, 383-391.
43. Buetler, T.M., Gallagher, Wang, C., Stahl, D.L., Hayes, J.D. and Eaton, D.L. (1995) Induction of phase I and phase II drug metabolising enzyme mRNA, protein and activity by BHA, ethoxyquin, and Oltipraz. Toxicol. Appl. Pharmacol., 135, 45-57.
44. Heaney, R.K., Spinks, E.A. and Fenwick, G.R. (1988) Improved method for the determination of the total glucosinolate content of rapeseed by determination of enzymatically released glucose. Analyst, 113, 1515-1518.
45. Omura, T. and Sato, R. (1964) The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem., 239, 2370-2378.
46. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione S-transferases. The first enzymic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
47. 1-8,9-epoxide. Biochem. J., 279, 385-398.
48. Prochaska, H.J. and Santamaria, A.B. (1988) Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtitre wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem., 169, 328-336.
49. 1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity toward a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res., 53, 3887-3894.
50. Green, J.A. and Manson, M.M. (1992) Production of polyclonal antisera. In Manson, M.M. (Ed.) Methods in Molecular Biology, Vol. 10. Immunochemical Protocols. Humana Press, New Jersey, pp. 1-5.
51. 1-induced carcinogenesis. Int. J. Cancer, 34, 869-874.
52. 1 and susceptibilities to γ-glutamyl p-phenylene diamine mustard of γ-glutamyl transferase negative and positive cell lines. Carcinogenesis, 2, 661-670.
53. Davies, R., Edwards, R.E., Green, J.A., Legg, R.F., Snowden, R.T. and Manson, M.M. Antioxidants can delay liver cell maturation which in turn affects γ-glutamyl transpeptidase expression. Carcinogenesis, 14, 47-52.
54. 1 biotransformation in rat liver: implications for human chemointervention. Cancer Res., 56, 2306-2313.
55. 1 by rat liver microsomes and isolated hepatocytes in vitro. Chem.-Biol. Interactions, 35, 145-157.
56. Zhang, Y. and Talalay, P. (1994) Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res., Suppl. 54, 1976s-1981s.
57. Furukawa, K., Maeura, Y., Furukawa, N.T. and Williams, G.M. (1984) Induction by butylated hydroxytoluene of rat liver γ-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesions. Chem.-Biol. Interactions, 48, 43-58.
58. Hayes, J.D., Nguyen, T., Judah, D.J., Petersson, D.G. and Neal, G.E. (1994) Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. J. Biol. Chem., 269, 20707-20717.
59. 1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett., 104, 49-53.
60. Lin, L., Yang, F., Ye, Z., Xu, E., Yang, C., Zhang, C., Wu, D. and Nebert, D.W. (1991) Case control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. Pharmacogenetics, 1, 79-85.
61. 1. Cancer Res., 54, 101-108.
62. 1 metabolism in human liver. Proc. Natl Acad. Sci. USA, 87, 8306-8310.
63. Huttunen, J.K. (1996) Why did antioxidants not protect against lung cancer in the alpha-tocopherol, β-carotene cancer prevention study? In Hakama, M., Beral, V., Buiatti, E., Faivre, J. and Parkin, D.M. (eds) Chemoprevention in Cancer Control. IARC Scientific publications No. 136, IARC, Lyon, France.
64. Morel, F., Fardel, O., Meyer, D.J., Langouet, S., Gilmore, K.S., Meunier, B., Tu, C.-P.D., Kensler, T.W., Ketterer, B. and Guillouzo, A. (1993) Preferential increase of glutathione S-transferase class α transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones. Cancer Res., 53, 231-234.
65. Kensler, T.W. (1994) The suppression of aflatoxin hepatocarcinogenesis by oltipraz: mechanisms and clinical opportunities. Proc. Am. Assoc. Cancer Res., 35, 696-697.
66. 1 metabolism in human hepatocytes in primary culture. Cancer Res., 55, 5574-5579.
67. 1. Carcinogenesis, 8, 723-728.
68. 1 induced hepatotoxicity. Biochem. Biophys. Res. Commun., 114, 813-821.
69. 1 with reduced glutathione, catalysed by cytosolic glutathione S-transferases in livers of rats, mice and guinea pigs. Biochem. Pharmacol., 36, 4269-4276.
70. 1-induced 8-hydroxydeoxy guanosine formation in rat hepatic DNA. Carcinogenesis, 16, 419-422.
71. Nebert, D.W., Peterson, D.D. and Fornace, A.J. (1990) Cellular responses to oxidative stress: The [Ah] gene battery as a paradigm. Environ. Health Persp., 88, 13-25.
72. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W.W., Fong, H.H.S., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C. and Pezzuto, J.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
73. Sharma, S., Stutzman, J.D., Kelloff, G.J. and Steele, V.E. (1994) Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res., 54, 5848-5855.
74. 1 hepatocarcinogenesis. Carcinogenesis, 2, 457-161.
75. Lieberman, M.W., Wiseman, A.L., Shi, Z.-Z., Carter, B.Z., Barrios, R., Ou, C.-N., Chevez-Barrios, P., Wang, Y, Habib, G.M., Goodman, J.C., Huang, S.L., Lebovitz, R.M. and Matzuk, M.M. (1996) Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc. Natl Acad. Sci. USA, 93, 7923-7926.
76. Dekant, W., Vamvakas, S. and Anders, M.W. (1989) Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate-β-lyase. Drug Metab. Rev., 20, 43-83.